Ethan R Schwartz, PHD | |
2340 Ward St Ste 204, Berkeley, CA 94705-1147 | |
(510) 658-5887 | |
Not Available |
Full Name | Ethan R Schwartz |
---|---|
Gender | Male |
Speciality | Psychologist - Counseling |
Location | 2340 Ward St Ste 204, Berkeley, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003041385 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC1900X | Psychologist - Counseling | PSY20986 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ethan R Schwartz, PHD 2340 Ward St Ste 204, Berkeley, CA 94705-1147 Ph: (510) 658-5887 | Ethan R Schwartz, PHD 2340 Ward St Ste 204, Berkeley, CA 94705-1147 Ph: (510) 658-5887 |
News Archive
With three town hall meetings in the past in the past week, President Obama and Democrats are staying in campaign mode on their push for reform, The Washington Post reports.
A handful of FDA-approved drugs exist for treating individuals with alcohol use disorder but they have been largely ineffective at reducing the high rates of relapse. As such, there remains a critical need to identify and develop alternative pharmacological treatment options.
Australian biotechnology and pharmaceutical companies are seeking to understand the implications of the US Healthcare Reform Bill, says Australia's biotechnology industry organisation, AusBiotech. In order to remain compliant and globally competitive, biotechs need to identify and work within a gamut of new requirements, complications and hurdles imposed by this new regulatory environment.
Despite advances in managing and curing some forms of breast cancer, women whose disease becomes metastatic have fewer effective options. A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant disease, showed that the newly approved drug, palbociclib, more than doubled the time to cancer recurrence for women with hormone-receptor (HR+) positive metastatic breast cancer.
Aggressive research currently underway brings hope of dramatic advances in breast cancer management, according to a new review.
› Verified 4 days ago
Samuel Doong, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2514 Piedmont Ave Apt 105, Berkeley, CA 94704 Phone: 909-380-3463 | |
Himadhari Sharma, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2222 Bancroft Way Spc 4300, Berkeley, CA 94720 Phone: 510-642-9494 Fax: 510-642-2368 | |
Dr. Lenora M Poe, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2034 Blake St, #1, Berkeley, CA 94704 Phone: 510-845-7189 Fax: 510-845-2330 | |
Dr. Michael Christopher Changaris, PSY.D. LIC#:PSY24712 Psychologist Medicare: Medicare Enrolled Practice Location: 771 San Luis Rd, Berkeley, CA 94707 Phone: 510-214-2559 | |
Dr. Matthew Reader Goodman, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2222 Bancroft Way Spc 4300, Berkeley, CA 94720 Phone: 510-642-0695 | |
Dr. Rachael Arline Peltz, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3120 Telegraph Ave, Suite #1, Berkeley, CA 94705 Phone: 510-841-3201 |